Neonatal jaundice epidemiology and demographics

Revision as of 19:45, 15 February 2018 by Anmol Pitliya (talk | contribs)
Jump to navigation Jump to search

Neonatal jaundice Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Neonatal jaundice from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Neonatal jaundice epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Neonatal jaundice epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Neonatal jaundice epidemiology and demographics

on Neonatal jaundice epidemiology and demographics

Neonatal jaundice epidemiology and demographics in the news

Blogs on Neonatal jaundice epidemiology and demographics

Directions to Hospitals Treating Neonatal jaundice

Risk calculators and risk factors for Neonatal jaundice epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]

Overview

The prevalence of neonatal jaundice ranges from 60,000 to 70,000 per 100,000 neonates. The prevalence of the neonatal jaundice decreases as the gestational age of the neonate increases. The prevalence of neonatal jaundice is more in the East Asian, American Indian, and Greek races.

Epidemilogy and Demographics

Prevalence

  • The prevalence of neonatal jaundice ranges from a low of 60,000 to high of 70,000 per 100,000 neonates in the first week of birth. [1]
  • The prevalence of severe hyperbilirubinemia ranges from a low of 8,000 to high of 9,000 per neonates in the first week of birth.

Age

  • The prevalence of neonatal jaundice decreases as the gestational age increases.[2]

Gender

  • Neonatal jaundice affects male more than female neonates.

Race

  • The prevalence of neonatal jaundice is more in the East Asian, American Indian, and Greek races.
  • Black races are less likely to develop jaundice. Black neonates presenting with jaundice most probably have G6PD deficiency disease.

References

  1. Smitherman, Hannah; Stark, Ann R.; Bhutan, Vinod K. (2006). "Early recognition of neonatal hyperbilirubinemia and its emergent management". Seminars in Fetal and Neonatal Medicine. 11 (3): 214–224. doi:10.1016/j.siny.2006.02.002. ISSN 1744-165X.
  2. Maisels, M. J. (2006). "Transcutaneous Bilirubin Levels in the First 96 Hours in a Normal Newborn Population of >=35 Weeks' Gestation". PEDIATRICS. 117 (4): 1169–1173. doi:10.1542/peds.2005-0744. ISSN 0031-4005.

​​

Template:WH Template:WS